Angiotensin receptor blockers may reduce progression from mild cognitive impairment to dementia in patients undergoing antihypertensive treatment, researchers wrote in Hypertension. Compared with ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease, including anemia, iron deficiency and “continued mucosal damage in the small ...

Cite this: Angiotensin Receptor Blockers and Secondary Stroke Prevention: The MOSES Study - Medscape - May 01, 2009. Abstract and Introduction Background & Rationale of MOSES ...

Study: Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.Image Credit: Kateryna Kon / Shutterstock. Background ...

Overall, people taking angiotensin receptor blockers had a 20% to 30% lower risk of developing epilepsy between 2010 and 2017 compared with people taking other blood pressure drugs.

Association of angiotensin receptor blockers with incident Parkinson disease in patients with hypertension: A retrospective cohort study. Am J Med . 2022 May 14;S0002-9343(22)00351-5. doi:10.1016 ...

ACE inhibitors and ARBs (angiotensin-receptor blockers) both have protective effects against atrial fibrillation, or AFib. Learn how they work to lower blood pressure and protect your heart.

Sidebar: Key Issues . In patients with stroke or transient ischemic attack, the angiotensin receptor blocker (ARB) eprosartan reduced combined total cardiac and cerebral event rates compared with ...